Showing results (171-180 of 183) with videos related to
Sort By:
Pageof 19
Molecular Cancer Therapeutics|October 28, 2010
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal modelsCurtis B Thompson, H Michael Shepard, Patrick M O'Connor, et al.Journal of the American Animal Hospital Association|September 21, 2001
Radiation therapy in the treatment of canine and feline thymomas: a retrospective study (1985-1999)A N Smith, J C Wright, W R Brawner, et al.The AAPS Journal|May 14, 2015
Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug AdministrationSanna Rosengren, Samuel S Dychter, Marie A Printz, et al.Annals of Internal Medicine|April 6, 2005
Meta-analysis: surgical treatment of obesityMelinda A Maggard, Lisa R Shugarman, Marika Suttorp, et al.Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatmentI A Atencio, J B Avanzini, D Johnson, et al.Gene Therapy|September 9, 2011
Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeysR W Veneziale, N S Kishnani, J Nelson, et al.Annals of Clinical and Translational Neurology|March 10, 2017
PH20 is not expressed in murine CNS and oligodendrocyte precursor cellsMathieu Marella, Joe Ouyang, Jonathan Zombeck, et al.American Journal of Human Genetics|June 5, 2013
A recurrent PDGFRB mutation causes familial infantile myofibromatosisYee Him Cheung, Tenzin Gayden, Philippe M Campeau, et al.Neurology|May 9, 2008
Cell-based interventions for neurologic conditions: ethical challenges for early human trialsD J H Mathews, J Sugarman, H Bok, et al.Pageof 19